C

Curis
D

CRIS

0.31400
USD
0.11
(54.99%)
قبل الجلسة·0.29500USD-0.01900(-6.05%)
حجم التداول
10,123
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
12,239,310
أصول ذات صلة المقالات
المزيد

العنوان: Curis

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.